IL138589A - Antitumor factors - Google Patents
Antitumor factorsInfo
- Publication number
- IL138589A IL138589A IL13858999A IL13858999A IL138589A IL 138589 A IL138589 A IL 138589A IL 13858999 A IL13858999 A IL 13858999A IL 13858999 A IL13858999 A IL 13858999A IL 138589 A IL138589 A IL 138589A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- alkylamino
- amino
- alkoxy
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/34—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805866.2A GB9805866D0 (en) | 1998-03-20 | 1998-03-20 | Anti-tumour agents |
| PCT/GB1999/000787 WO1999048857A1 (en) | 1998-03-20 | 1999-03-16 | Anti-tumour agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL138589A0 IL138589A0 (en) | 2001-10-31 |
| IL138589A true IL138589A (en) | 2004-08-31 |
Family
ID=10828858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13858999A IL138589A (en) | 1998-03-20 | 1999-03-16 | Antitumor factors |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6346633B1 (de) |
| EP (1) | EP1064253B1 (de) |
| JP (1) | JP2002507590A (de) |
| KR (1) | KR20010042055A (de) |
| CN (1) | CN1293654A (de) |
| AT (1) | ATE231835T1 (de) |
| AU (1) | AU756651B2 (de) |
| BR (1) | BR9908932A (de) |
| CA (1) | CA2324361A1 (de) |
| DE (1) | DE69905142T2 (de) |
| DK (1) | DK1064253T3 (de) |
| ES (1) | ES2190199T3 (de) |
| GB (1) | GB9805866D0 (de) |
| IL (1) | IL138589A (de) |
| NO (1) | NO20004662L (de) |
| NZ (1) | NZ505856A (de) |
| WO (1) | WO1999048857A1 (de) |
| ZA (1) | ZA200004387B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9805868D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
| US20060099712A1 (en) * | 2004-11-08 | 2006-05-11 | Eastman Kodak Company | Correlation of anti-cancer activity of dyes with redox potentials |
| AU2017291411A1 (en) * | 2016-06-27 | 2019-01-03 | Systems Oncology, Llc | Combination chemotherapies |
| WO2020210831A1 (en) * | 2019-04-12 | 2020-10-15 | TONIX Pharmaceuticals Holding Corp | Inhibitors of cd40-cd154 binding |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2862107D1 (en) | 1977-12-02 | 1982-11-18 | Takeda Chemical Industries Ltd | Glucosamine-peptide derivatives and their pharmaceutical compositions |
| JPS58177934A (ja) | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
| NZ240785A (en) * | 1991-11-28 | 1995-08-28 | Cancer Res Campaign Tech | Substituted nitro aniline derivatives and medicaments |
| GB9805868D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
-
1998
- 1998-03-20 GB GBGB9805866.2A patent/GB9805866D0/en not_active Ceased
-
1999
- 1999-03-16 BR BR9908932-7A patent/BR9908932A/pt not_active IP Right Cessation
- 1999-03-16 IL IL13858999A patent/IL138589A/en not_active IP Right Cessation
- 1999-03-16 EP EP99909099A patent/EP1064253B1/de not_active Expired - Lifetime
- 1999-03-16 DE DE69905142T patent/DE69905142T2/de not_active Expired - Fee Related
- 1999-03-16 CN CN99804243A patent/CN1293654A/zh active Pending
- 1999-03-16 ES ES99909099T patent/ES2190199T3/es not_active Expired - Lifetime
- 1999-03-16 AU AU28468/99A patent/AU756651B2/en not_active Ceased
- 1999-03-16 JP JP2000537842A patent/JP2002507590A/ja active Pending
- 1999-03-16 CA CA002324361A patent/CA2324361A1/en not_active Abandoned
- 1999-03-16 NZ NZ505856A patent/NZ505856A/xx unknown
- 1999-03-16 US US09/646,459 patent/US6346633B1/en not_active Expired - Fee Related
- 1999-03-16 DK DK99909099T patent/DK1064253T3/da active
- 1999-03-16 AT AT99909099T patent/ATE231835T1/de not_active IP Right Cessation
- 1999-03-16 KR KR1020007010399A patent/KR20010042055A/ko not_active Application Discontinuation
- 1999-03-16 WO PCT/GB1999/000787 patent/WO1999048857A1/en not_active Application Discontinuation
-
2000
- 2000-08-24 ZA ZA200004387A patent/ZA200004387B/xx unknown
- 2000-09-19 NO NO20004662A patent/NO20004662L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ505856A (en) | 2002-09-27 |
| DK1064253T3 (da) | 2003-06-23 |
| BR9908932A (pt) | 2005-10-25 |
| DE69905142D1 (de) | 2003-03-06 |
| AU756651B2 (en) | 2003-01-16 |
| DE69905142T2 (de) | 2003-10-16 |
| EP1064253B1 (de) | 2003-01-29 |
| EP1064253A1 (de) | 2001-01-03 |
| CN1293654A (zh) | 2001-05-02 |
| AU2846899A (en) | 1999-10-18 |
| IL138589A0 (en) | 2001-10-31 |
| ZA200004387B (en) | 2001-10-31 |
| US6346633B1 (en) | 2002-02-12 |
| GB9805866D0 (en) | 1998-05-13 |
| KR20010042055A (ko) | 2001-05-25 |
| WO1999048857A1 (en) | 1999-09-30 |
| NO20004662D0 (no) | 2000-09-19 |
| JP2002507590A (ja) | 2002-03-12 |
| NO20004662L (no) | 2000-11-17 |
| CA2324361A1 (en) | 1999-09-30 |
| ATE231835T1 (de) | 2003-02-15 |
| ES2190199T3 (es) | 2003-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050277627A1 (en) | Colchinol derivatives as vascular damaging agents | |
| CA2217771C (en) | O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same | |
| SK52003A3 (en) | Colchinol derivatives as angiogenesis inhibitors, method for their preparation and pharmaceutical composition comprising the same | |
| AU2001266233A1 (en) | Colchinol derivatives as vascular damaging agents | |
| BG107889A (bg) | Тетралонови производни като антитуморни средства | |
| AU746715B2 (en) | Anti-tumour agents | |
| CA2442994A1 (en) | Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors | |
| Schmidt et al. | Inhibitors of histone deacetylase suppress the growth of MCF‐7 breast cancer cells | |
| JP2011503165A (ja) | １７β−ヒドロキシステロイドデヒドロゲナーゼのインヒビター | |
| EP0009944B1 (de) | Lysosomotropische therapeutische fluorierte Aminverbindungen und sie enthaltende Zusammensetzungen | |
| EP1064253B1 (de) | Anti-tumor-mittel | |
| JP2005532280A (ja) | 化合物 | |
| CN107207561B (zh) | 17β-HSD1–抑制剂的前药 | |
| TW201922690A (zh) | 環－amp反應元素結合蛋白的抑制劑 | |
| EP3628664A1 (de) | Irreversible inhibitoren der kras-g12c-mutante | |
| WO1993023364A1 (fr) | Nouveaux derives de la dihydroxybenzylamine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| MXPA00008646A (en) | Anti-tumour agents | |
| MXPA00008910A (es) | Agentes anti-tumorales | |
| AU2011325809B2 (en) | Benzamide derivative with anticancer activity and preparation method and use thereof | |
| KR100273603B1 (ko) | 치환된 벤조에이트 유도체 | |
| US20040142909A1 (en) | Colchinol derivatives as angiogenesis inhibitors | |
| JPH04500359A (ja) | 最終分化に有効な新規誘発物質およびその使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |